GB0424552D0 - Methods and means - Google Patents

Methods and means

Info

Publication number
GB0424552D0
GB0424552D0 GB0424552A GB0424552A GB0424552D0 GB 0424552 D0 GB0424552 D0 GB 0424552D0 GB 0424552 A GB0424552 A GB 0424552A GB 0424552 A GB0424552 A GB 0424552A GB 0424552 D0 GB0424552 D0 GB 0424552D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0424552A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Theranostics Ltd
Original Assignee
Cambridge Theranostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Theranostics Ltd filed Critical Cambridge Theranostics Ltd
Priority to GB0424552A priority Critical patent/GB0424552D0/en
Publication of GB0424552D0 publication Critical patent/GB0424552D0/en
Priority to JP2007539628A priority patent/JP2008519018A/ja
Priority to CNA200580041763XA priority patent/CN101072573A/zh
Priority to US11/666,726 priority patent/US20080166330A1/en
Priority to EP05798233A priority patent/EP1812024A1/en
Priority to PCT/GB2005/004215 priority patent/WO2006048628A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0424552A 2004-11-05 2004-11-05 Methods and means Ceased GB0424552D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0424552A GB0424552D0 (en) 2004-11-05 2004-11-05 Methods and means
JP2007539628A JP2008519018A (ja) 2004-11-05 2005-11-01 アテローム硬化性疾患の予防又は治療のための細菌組成物
CNA200580041763XA CN101072573A (zh) 2004-11-05 2005-11-01 用于预防或治疗动脉粥样硬化疾病的细菌组合物
US11/666,726 US20080166330A1 (en) 2004-11-05 2005-11-01 Bacterial Compositions For Prevention Or Treatment Of Atherosclerotic Disorders
EP05798233A EP1812024A1 (en) 2004-11-05 2005-11-01 Bacterial compositions for prevention or treatment of atherosclerotic disorders
PCT/GB2005/004215 WO2006048628A1 (en) 2004-11-05 2005-11-01 Bacterial compositions for prevention or treatment of atherosclerotic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424552A GB0424552D0 (en) 2004-11-05 2004-11-05 Methods and means

Publications (1)

Publication Number Publication Date
GB0424552D0 true GB0424552D0 (en) 2004-12-08

Family

ID=33523284

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0424552A Ceased GB0424552D0 (en) 2004-11-05 2004-11-05 Methods and means

Country Status (6)

Country Link
US (1) US20080166330A1 (https=)
EP (1) EP1812024A1 (https=)
JP (1) JP2008519018A (https=)
CN (1) CN101072573A (https=)
GB (1) GB0424552D0 (https=)
WO (1) WO2006048628A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
US20110189149A1 (en) * 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria
US8777025B1 (en) * 2011-08-18 2014-07-15 Whirlpool Corporation Modular hanging solutions for a household appliance
CN107208037A (zh) * 2014-09-30 2017-09-26 深圳华大基因科技有限公司 拟杆菌属在预防和治疗冠状动脉疾病中的用途
WO2016049826A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Use of bacteroides in the prevention and treatment for coronary artery disease
WO2018181071A1 (ja) * 2017-03-28 2018-10-04 森永乳業株式会社 非コラーゲン性糖タンパク質分解用組成物
CN121421987A (zh) * 2025-12-31 2026-01-30 中国医学科学院生物医学工程研究所 抗体靶向修饰双菌-益生元递送系统及制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS61109729A (ja) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
DE69426186T2 (de) * 1993-05-11 2001-05-17 Otsuka Pharma Co Ltd Antioxidans-nahrungsmittel, antioxidans-herstellung und methode zur verringerung der oxidation
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
DE69929321T2 (de) * 1998-04-01 2006-09-14 Ganeden Biotech, Inc., San Diego Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
GB2380481B (en) * 2001-08-22 2003-12-03 Cambridge Theranostics Ltd Means for treatment of atherosclerosis

Also Published As

Publication number Publication date
US20080166330A1 (en) 2008-07-10
WO2006048628A1 (en) 2006-05-11
JP2008519018A (ja) 2008-06-05
CN101072573A (zh) 2007-11-14
EP1812024A1 (en) 2007-08-01

Similar Documents

Publication Publication Date Title
GB0822148D0 (en) Methods and apparatus
EP1819226A4 (en) COMBINATIONS AND METHODS OF IMMUNOSTIMULATION
EP1802588A4 (en) SUBSTITUTED AMINOPYRIMIDONE AND APPLICATIONS THEREOF
EP1737565A4 (en) COS CLAUS CONFIGURATIONS AND METHODS
IL184062A0 (en) Visco-supplement composition and methods
IL179497A0 (en) Carboranylporphyrins and uses thereof
SG119251A1 (en) Methods
GB0412475D0 (en) Device and method
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
GB0426903D0 (en) Complexes and methods
EP1804703A4 (en) CRYO-SURGICAL APPARATUS AND RELATED METHODS
GB0424552D0 (en) Methods and means
GB0407382D0 (en) Therapeutic methods and means
IL180365A0 (en) Carboranylporphyrins and uses thereof
GB0403629D0 (en) Methods
GB0403847D0 (en) Methods and means
GB0407985D0 (en) Device and method
GB0407976D0 (en) Device and method
GB0421911D0 (en) Methods and means
GB0423552D0 (en) Methods
ZA200706038B (en) Visco-supplement composition and methods
GB0407968D0 (en) Device and method
EP1938123A4 (en) SHIELD STRUCTURE AND METHOD
GB0419181D0 (en) Methods and means
GB0421466D0 (en) Methods and means

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)